ASSOCIATION OF LABORATORY MARKERS WITH THE DURATION OF JAUNDICE IN COMPLICATED CHOLEDOCHOLITHIASIS
DOI:
https://doi.org/10.11603/mcch.2410-681X.2025.i4.15918Keywords:
choledocholithiasis; cholangitis; biliary pancreatitis; jaundice; L-FABP; gammaglutamyl transpeptidase; total bilirubin; aminotransferases.Abstract
Introduction. Choledocholithiasis is a common complication of gallstone disease, with a frequency ranging from 8 to 16 %. Untreated choledocholithiasis can be a common cause of repeated hospital visits and progress to life-threatening complications, including acute cholangitis or biliary pancreatitis. Scientific data show that the presence of jaundice is one of the significant clinical predictors of gallstone disease. Prolonged mechanical jaundice significantly increases the risk of hepatic-renal failure, biliary sepsis, and acute cholangitis, which directly correlates with high postoperative morbidity and mortality. The Aim of the Study – to establish the relationship between the duration of jaundice and laboratory markers in patients with choledocholithiasis complicated by cholangitis and biliary pancreatitis. Research Methods. The study included a clinical examination and analysis of laboratory data from 122 inpatients with choledocholithiasis (ChL), complicated either by cholangitis (n = 59) or biliary pancreatitis (n = 63) upon admission. Results and Discussion. Comparative analysis of laboratory parameters in patients with complicated choledocholithiasis demonstrated significant differences between the observation groups. Analysis of associations between the duration of jaundice and laboratory markers showed no correlation between the level of gammaglutamyl transpeptidase (GGT) and the duration of jaundice in the cholangitis group. In contrast, complications involving biliary pancreatitis were accompanied by a weak positive correlation between the investigated parameters. A significant positive correlation was established between the level of L-FABP, ALT and total bilirubin with the duration of jaundice in ChL patients complicated by both cholangitis and biliary pancreatitis. Conclusions. Patients with choledocholithiasis complicated by cholangitis exhibit a significantly more pronounced cytolytic syndrome and hepatocyte damage compared to those with biliary pancreatitis. This is confirmed by reliably higher levels of L-FABP (by 1,35 times), ALT (by 1,51 times), and AST (by 1,55 times) (p < 0,05). The greatest prognostic significance regarding the duration of jaundice in biliary pancreatitis belongs to total bilirubin (r = 0,50), indicating a direct dependence of bilirubin accumulation on the time of persistent obstruction, whereas GGT was found to be uninformative for predicting the duration of obstruction in cholangitis.
References
Lyu Y., Cheng Y., Li T., Cheng B., Jin X. Laparoscopic common bile duct exploration plus cholecystectomy versus endoscopic retrograde cholangiopancreatography plus laparoscopic cholecystectomy for cholecystocholedocholithiasis: a meta-analysis. Surgical Endoscopy. 2019. Vol. 33. P. 3275–3286. DOI: 10.1007/ s00464-018-06613-w
Zouki J., Sidhom D., Bindon R., Sidhu T., Chan E., Lyon M. Choledocholithiasis: A review of management and outcomes in a regional setting. Cureus. 2023. Vol. 15. № 12. P. e50223. DOI: 10.7759/cureus.50223
McNicoll C. F., Pastorino A., Farooq U. et al. Choledocholithiasis. StatPearls. Treasure Island (FL) : StatPearls Publishing, 2025. URL: https://www.ncbi.nlm.nih.gov/books/NBK441961/ (дата звернення: 12.10.2025).
Frybova B., Drabek J., Lochmannova J., Douda L., Hlava S., Zemkova D., Mixa V., Kyncl M., Zeman L., Rygl M., Keil R. Cholelithiasis and choledocholithiasis in children: risk factors for development. PLoS ONE. 2018. Vol. 13. № 5. P. e0196475. DOI: 10.1371/journal.pone.0196475
Wilkins T., Agabin E., Varghese J., Talukder A. Gallbladder dysfunction: Cholecystitis, choledocholithiasis, cholangitis, and biliary dyskinesia. Primary Care. 2017. Vol. 44. № 4. P. 575–597. DOI: 10.1016/j.pop.2017.07.001
Li S., Guizzetti L., Ma C. et al. Epidemiology and outcomes of choledocholithiasis and cholangitis in the United States: trends and urban-rural variations. BMC Gastroenterology. 2023. Vol. 23. P. 254. DOI: 10.1186/ s12876-023-02868-3
Гаврилов С. О., Грищук А. Ю. Діагностична та прогностична роль біохімічних показників при механіч- ній жовтяниці. Медична наука та практика. 2018. Т. 3. № 2.
Mayumi T., Okamoto K., Takada T. та ін. Tokyo Guidelines 2018: Management bundles for acute cholangitis and cholecystitis. Journal of Hepato-Biliary- Pancreatic Sciences. 2018. Vol. 25. № 1. P. 96–100. DOI: 10.1002/jhbp.519
Takada T., Isaji S., Mayumi T. et al. JPN clinical practice guidelines 2021 with easy-to-understand explanations for the management of acute pancreatitis. Journal of Hepato-Biliary-Pancreatic Sciences. 2022. Vol. 29. P. 1057–1083. DOI: 10.1002/jhbp.1146
Практична психосоматика: діагностичні шкали : навчальний посібник / за ред. О. О. Чабана, О. О. Хаустової. 2-ге вид., випр. і доп. Київ : Видавни- чий дім «Медкнига», 2019. 112 с.
Mazumdar A., Singh V., Singh R. Clinical profile and outcome of patients with acute obstructive jaundice. Indian Journal of Surgery. 2018. Vol. 80. № 6. P. 614–618. DOI: 10.1007/s12262-018-1802-5
Li S., Huang J., Li Y., Wang F., Zhou Y. Risk factors for the severity of acute cholangitis: A retrospective cohort study. BMC Gastroenterology. 2020. Vol. 20. № 1. P. 125. DOI: 10.1186/s12876-020-01264-5
Kiriyama S., Takada T., Hwang T. et al. Clinical features and severity grading of acute cholangitis and cholecystitis (Tokyo Guidelines 2018). Journal of Hepato- Biliary-Pancreatic Sciences. 2018. Vol. 25. № 1. P. 17–30. DOI: 10.1002/jhbp.512
Pradines C. et al. Assessment of biliary obstruction using liver function tests: Correlation with clinical outcomes. Annals of Surgery. 2020. Vol. 272. № 5. P. 987–994. DOI: 10.1097/ SLA.0000000000003571
Miyoshi S., Ohkohchi N., Sato M., Hoshi K., Satomi S., Orikasa Y. Liver-type fatty acid binding protein (L-FABP) as a biomarker for early diagnosis of liver injury. Journal of Clinical Biochemistry and Nutrition. 2018. Vol. 63. № 1. P. 1–8. DOI: 10.3164/jcbn.18-15
Zhong C. B., Huang Y., Liu Y. H., Fan X. M., Shi H. T. Pathophysiological role of bile acid metabolism in obstructive jaundice. World Journal of Gastroenterology. 2020. Vol. 26. № 47. P. 7437–7448. DOI: 10.3748/wjg. v26.i47.7437
Vroonhof J. M. et al. Timing of intervention in acute obstructive jaundice: A systematic review and meta-analysis. HPB. 2020. Vol. 22. № 8. P. 1113–1123. DOI: 10.1016/j.hpb.2020.03.002
Lala H. et al. The clinical significance of liver function tests in obstructive jaundice: A retrospective analysis. International Journal of Clinical Practice. 2021. Vol. 75. № 11. P. e14749. DOI: 10.1111/ ijcp.14749
Tse F., Barkun A. N. The management of suspected choledocholithiasis in patients undergoing laparoscopic cholecystectomy. Current Gastroenterology Reports. 2019. Vol. 11. № 6. P. 409–417. DOI: 10.1007/ s11894-009-0065-3
Lankisch P. G., Appelt M., Görlich J. Acute biliary pancreatitis: current concepts and future directions. Digestive Diseases. 2017. Vol. 35. № 2. P. 177–183. DOI: 10.1159/000450674
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Medical and Clinical Chemistry

This work is licensed under a Creative Commons Attribution 4.0 International License.